The results revealed that its expression was significantly lower in primary CD34+ and bone marrow mononuclear cells (BMMNCs) from patients with ET and PV, compared to those from healthy volunteers, at both mRNA and protein levels (Fig. 1a–c). Here, CD34 is linked to acquired polycythemia vera.